CRISPR gene-edited tomatoes — with as much provitamin D as two eggs — could soon be sold in Britain

Credit: Digital Art/Fuse
Credit: Digital Art/Fuse

Scientists have created genetically edited tomatoes, each containing as much provitamin D3 – the precursor to vitamin D – as two eggs or a tablespoon of tuna.

Outdoor field trials of the tomatoes are expected to begin in the UK next month, and if successful, could provide an important new dietary source of vitamin D.

Follow the latest news and policy debates on sustainable agriculture, biomedicine, and other ‘disruptive’ innovations. Subscribe to our newsletter.

Approximately 13-19% of Britons have low levels of vitamin D, which is needed to keep bones, teeth and muscles healthy. Our main source of this nutrient comes from exposing the skin to sunlight, which converts provitamin D3 into an active form of vitamin D that our bodies can use.

However, in the UK there is only enough sunlight to achieve this between April and September, meaning we have to rely on dietary sources – such as oily fish, red meat, egg yolks and mushrooms – or supplements. This is particularly challenging for vegans, as many supplements contain lanolin from sheep’s wool.

“Gene-editing tomatoes to accumulate provitamin D3 at levels above recommended dietary guidelines could result in better health for many especially as tomatoes are a widely accessible and readily eaten food,” said Guy Poppy, a professor of ecology at the University of Southampton.

This is an excerpt. Read the original post here

{{ reviewsTotal }}{{ options.labels.singularReviewCountLabel }}
{{ reviewsTotal }}{{ options.labels.pluralReviewCountLabel }}
{{ options.labels.newReviewButton }}
{{ userData.canReview.message }}

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

Screenshot 2026-05-26 at 10.15
Viewpoint: Double standard—Why does the wellness industry get a free pass while Big Healthcare is treated as morally suspect?
ChatGPT-Image-Jun-4-2026-11_49_36-AM-2
‘You don’t understand Tolkien’: Skeptic Pope trolls tech giants about the exaggerated, risk-less benefits of AI
Screenshot-2026-06-04-at-12.05.08-PM
Cases of brain inflammation surge as U.S. measles pandemic approaches 2000
ChatGPT-Image-Jun-4-2026-01_27_58-PM
Viewpoint—N.A.D.+: Why Gwenyth Paltrow’s heralded anti-aging supplement doesn’t work
Screenshot 2025-07-30 at 10.48
Can gene editing eliminate Down syndrome? Scientists have done it in lab-grown cells
ChatGPT Image May 26, 2026, 08_42_17 AM (1)
Viewpoint: Greenpeace and poison: How environmental advocacy groups rely on compliant (and often ignorant) journalists to spread disinformation and spark litigation
Screenshot-2026-06-03-at-1.24.46-PM
Challenging anti-GMO disinformation: Why genetically-tweaked crops offer bushels of benefits
ChatGPT-Image-Mar-10-2026-01_39_01-PM
Viewpoint—“Miracle molecule” debunked: Why acemannan supplements don’t work
downsyndrome_compilation_MID_1
CRISPR breakthrough that can remove the chromosome responsible for Down syndrome raises ethical questions
tick-DNA
GLP podcast: Spread meat allergy with gene-edited ticks? Bioethicists pose vile ‘thought experiment’
ChatGPT Image May 26, 2026, 08_21_36 AM
Limiting gender affirming interventions: Trump administration targets Texas even though it already bans youth access
Screenshot 2026-06-04 at 12.43
Viewpoint: Doctors who are battling Ebola are incredulous that U.S. government is not utilizing specially designed emergency health units meant to fight virulent disease
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.